Chiron’s 2nd-Quarter Profit Rises 23%
- Share via
From Bloomberg News
Chiron Corp., the third-biggest U.S. biotechnology company, said second-quarter profit climbed 23% as it sold more vaccines and blood tests.
Net income increased to $62 million, or 33 cents a share, from $50.4 million, or 26 cents, a year earlier, and revenue rose 17% to $350.3 million, the Emeryville, Calif.-based firm said.
Shares of Chiron, which announced its financial results after the close of U.S. markets, rose 63 cents to $48.15 on Nasdaq.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
